Latest News

Neutral Outcomes of Routine Colchicine and Spironolactone Treatments in MI Patients
Written by: Radcliffe Cardiology, Yazmin Sadik; Special Editor: Greg Guillory
CLEAR-SYNERGY: Neutral Outcomes of Routine Colchicine and Spironolactone Treatments in MI Patients
AHA 24: PALISADE Trial Shows Promise for Patients with Familial Chylomicronemia Syndrome
Written by: Radcliffe Cardiology, Jordan Rance; Special Editor: Greg Guillory
AHA 24: PALISADE Trial Shows Promise for Patients with Familial Chylomicronemia Syndrome
BPROAD: Promising Results for Intensive Blood Pressure Control in Type 2 Diabetes Patients
Written by: Radcliffe CVRM, Yazmin Sadik; Special Editor: Greg Guillory
BPROAD: Promising Results for Intensive Blood Pressure Control in Type 2 Diabetes Patients
ATTRibute-CM Open-Label Extension (OLE) Study: Sustained Benefits of Acoramidis in ATTR-CM
Written by: Radcliffe Cardiology, Jordan Rance; Special Editor: Greg Guillory
ATTRibute-CM Open-Label Extension (OLE) Study: Sustained Benefits of Acoramidis in ATTR-CM
AF Symposium 2025 Late-Breaking Programme
Written by: AF Symposium
AF Symposium 2025 Releases its Late-Breaking Scientific Programme
ESC Congress 2024 Reveals its Late-Breaking Scientific Sessions
Written by: ESC Congress, Radcliffe Cardiology
ESC Congress 2024 Reveals its Late-Breaking Scientific Sessions
ESC Congress 2024 Unveils its Hot Line Trials
Written by: Radcliffe Cardiology, ESC Congress
ESC Congress 2024 Unveils its Hot Line Trials
FLOW Trial Analysis: Deep Dive into the SGLT2-GLP-1 Combination Therapy
Written by: Radcliffe Cardiology, David Ramsey
FLOW Trial Analysis: Deep Dive into the SGLT2-GLP-1 Combination Therapy
Novel Agent Data for Obesity Released at ADA 2024 Scientific Sessions Show Benefits for Glycaemic and Blood Pressure Control
Written by: Radcliffe Cardiology, Jordan Rance
Novel Agent Data for Obesity Released at ADA 2024 Scientific Sessions Show Benefits for Glycaemic and Blood…
SURMOUNT-OSA: Tirzepatide Significantly Improves Sleep Apnea and Cardiometabolic Risk Factors
Written by: Radcliffe Cardiology, Jordan Rance
SURMOUNT-OSA: Tirzepatide Significantly Improves Sleep Apnea and Cardiometabolic Risk Factors

External news

Written by: Cardiovascular Business
Johnson & Johnson gains CE mark approval for catheter capable of radiofrequency, PFA ablation
Written by: Cardiovascular Business
Robotic mitral repair compares favorably to surgery—but some concerns remain
Written by: Cardiovascular Business
FDA has now cleared more than 1,000 AI models, including many in cardiology
Written by: Medscape
Change Makers: Richard Francis on the Pillars of Innovation
Written by: Cardiac Vascular News
Pulse Biosciences, Inc. Appoints Paul LaViolette as Chief Executive Officer
Written by: Medscape
Jan 10 2025 This Week in Cardiology
Written by: Cardiovascular Business
Compensation rising for cardiology APPs as they get more involved in patient care
Written by: Cardiovascular Business
Reimbursement update: What hospitals need to know about new Medicare payments for cardiac CT
Written by: Cardiovascular Business
Cardiologist remembered for his ‘great empathy, love and generosity’
Written by: Medscape
New Health Cybersecurity Rule: What Docs Should Know